Comparison

Azeliragon European Partner

Manufacturer TargetMol
Category
Type Molecules
Specific against other
Amount 200mg
Item no. TMO-T2507-200mg
CASRN 603148-36-3
eClass 6.1 32169090
eClass 9.0 32169090
Available
Bioactivity
TTP488 is an antagonist at the Receptor for Advanced Glycation End products, is evaluated as a potential treatment for patients with mild-to-moderate Alzheimer_acute_s disease (AD).
MolWt
532, 12
Pathways
Others
Receptor
RAGE

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200mg
Available: In stock
available

Delivery expected until 5/23/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close